Use the navigation bar to select year of news
click on the topic bars below to expand/contract for more information
News Items 2024
A symposium in Belgrade with EMERG researchers participating
New members of EMERG are announced and an update on the EMERG application
September 2024: - Young EMERG Workshop Spans Two Days
Next year's Young EMERG workshop will now be spread over two days during the International ME Conference Week
EMERG will meet up in UK in June, prior to the International ME Conference Week events at the Wellcome Genome Campus, between London and Cambridge, UK.
News Items 2023
News from EMERG member - Professor Dr Branislav Milovanović from Serbia - regarding a new symposium.
New members of EMERG are announced and an update on the EMERG application for EU Horizon funding for research into high burden, under-researched diseases - ME
New paper from Professor Maureen Hanson of Cornell University, USA.
The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome
Videos from the recent 15th International ME Conference organised by UK charity Invest in ME Research are available here
UK charity Invest in ME Research and EMERG announce the resumption of the European young/early career researcher network - Young EMERG. An additional event is now planned for International ME Conference Week for the group to meet, along with early career investigators from other countries and continents.
A full EMERG meeting will take place prior to the 12th Invest in ME Research Biomedical Research into ME Colloquium at the Wellcome Genome Campus in UK in May. EMERG will have new participants who will also be joining the meeting.
News Items 2022
EMERG members have collaborated in HPV research and the following paper has now been published -
Autoimmunity in patients reporting long-term complications after exposure
to human papilloma virus vaccination
Several EMERG researchers were involved in this paper - including EMERG co-chair Dr Jesper Mehlsen.
EMERG member Anders Rosén was a participant in the recently published paper -
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is
unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome
In June 2021 at UK charity Invest in ME Research's tenth annual International Biomedical Research into ME Colloquium
(#BRMEC10) ME researchers from around the world met up to discuss research, both past and current,
The agenda was created with the help of The European ME Research Group
and was developed to test popular hypotheses that explain the aetiology of ME.
These included: immunogenetics and dysfunctional immune responses; an abnormal autonomous nervous system
and autoimmunity; mitochondrial metabolic dysfunction; and altered host-microbe (commensal and pathogen)
interactions.
A paper has been published that summarises discussions in one of the hypotheses from one of the Colloquium
sessions - that immune dysfunction and viral factors may drive the development and progression of ME.
EMERG member Hanna Ollila has been granted an award from the Academy of Finland for research into ME.
This was one of 22 new Academy Research Fellows selected in biosciences, health and environmental research.
The selections emphasised the high scientific quality of the projects and international research cooperation.
EMERG will again play a major role in the annual international research Colloquium organised by UK charity
Invest in ME Research. This year will be the 11th Colloquium - #BRMEC11.
EMERG will be chairing sessions in the Colloquium.
News Items Archived
EMERG member from Spain, Professor Elisa Oltra, presented at the #BRMEC10 Colloquium recently. The Gene Expression and Immunity research group of the Faculty of Medicine and Health Sciences of the Catholic University of Valencia (UCV), where Elisa is the principal investigator, recently discussed her work and that of UCV research group member Karen Giménez.
Researchers in Bergen suggest that ME can be linked to a failure in the energy supply to the cells.
They compared blood samples from patients with ME and a control group.
Researchers at the University of Bergen and Haukeland University Hospital, among others, have found differences in blood samples from ME patients and healthy people.
EMERG played a major part in the recent 10th Invest in ME Research International Biomedical Research into ME Colloquium #BRMEC10
that was held recently.
The main part of the agenda was formulated by EMERG in collaboration with the UK charity.
A report will be available from the Invest in ME Research web site. More information will be in the EMERG site in due course.
A proposed research agenda has been submitted to the Dutch Minister of Health and includes research funding of € 20-29½ million over 10 years for a biomedical research program.
The prevalence of pediatric #mecfs 0.75%, a higher percentage being African American and Latinx than Caucasian. Less than 5% had been previously diagnosed with the illness. Jason, L.A., Katz, B.Z., Sunnquist, M. et al. Child Youth Care Forum (2020).
The USA ME Clinicians Council publishes Diagnosing and Treating - MYALGIC ENCEPHALOMYELITIS/ CHRONIC FATIGUE SYNDROME (ME/CFS)
Members of the The European ME Alliance (EMEA) have been working with European Federation of Neurological Associations (EFNA) to set up an awareness day for ME at the upcoming European Academy of Neurology Congress in Norway.
From Sweden - From Ewa Wadhagen Wedlund reg. occupational therapist, med.lic. ME/CFS center Stora Sköndal, Sweden
The following statement was issued by the European ME CLinicians Council following the inaugural workshop in London in February 2019